Senti Biosciences Holdings
SNTI
21 hedge funds and large institutions have $1.6M invested in Senti Biosciences Holdings in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 19 → 21 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
2.17% less ownership
Funds ownership: 18.6% → 16.44% (-2.2%)
84% less capital inflows, than outflows
Capital inflows: $175K | Capital outflows: $1.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
+$70.9K |
| 2 |
GTS Securities
Miami,
Florida
|
+$50.8K |
| 3 |
HRT Financial
New York
|
+$24.8K |
| 4 |
Virtu Financial
New York
|
+$11.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nantahala Capital Management
New Canaan,
Connecticut
|
-$977K |
| 2 |
Jane Street
New York
|
-$57.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$41.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.83K |
| 5 |
XTX Topco
George Town,
Cayman Islands
|
-$4.02K |
SNTI Hedge Fund Activity: Q3 2026 in Review
21 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q3 2026, worth a combined $1.6M — down 75% from $6.37M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SNTI positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $70.9K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $977K sold.
- 21 institutional investors held Senti Biosciences Holdings (SNTI) as of Q3 2026, up from 19 in Q2 2026.
- Funds reported $1.6M of Senti Biosciences Holdings stock for Q3 2026, down 75% quarter-over-quarter.
- 5 funds opened new Senti Biosciences Holdings positions in Q3 2026 and 3 closed out, a net change of +2 holders.
- The largest Senti Biosciences Holdings buyer in Q3 2026 was Two Sigma Securities, an estimated $70.9K added.
- The largest Senti Biosciences Holdings seller in Q3 2026 was Nantahala Capital Management, an estimated $977K sold.
Based on aggregated 13F filings for Q3 2026.